European Commission grants marketing authorisation for Vumerity
17 Nov 2021 //
EUROPEANPHARMACEUTICALREVIEW
Banner Life Sciences Announces BAFIERTAM, a Novel Oral Fumarate Treatment
03 Sep 2020 //
PRESS RELEASE
Banner Life Sciences Announces Commercial Launch of BAFIERTAM
16 Jul 2020 //
BUSINESSWIRE
Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS
01 May 2020 //
BUSINESSWIRE
Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for MS
30 Apr 2020 //
BUSINESSWIRE
Alkermes and Biogen announce new MS drug application for FDA
18 Dec 2018 //
PHARMA TIMES